Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: Systematic review of diagnostic test accuracy

被引:36
作者
de Boer, Peter [1 ]
Adam, Judit A. [2 ,3 ]
Buist, Marrije R. [4 ]
van de Vijver, Marc J. [5 ]
Rasch, Coen R. [1 ]
Stoker, Jaap [2 ]
Bipat, Shandra [2 ]
Stalpers, Lukas J. A. [1 ]
机构
[1] Univ Amsterdam, AMC, Dept Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands
[2] UvA, AMC, Dept Radiol, Amsterdam, Netherlands
[3] UvA, AMC, Dept Nucl Med, Amsterdam, Netherlands
[4] UvA, AMC, Dept Obstet & Gynaecol, Amsterdam, Netherlands
[5] UvA, AMC, Dept Pathol, Amsterdam, Netherlands
关键词
Uterine cervical neoplasms; Magnetic resonance imaging; Review; Neoplasm invasiveness; COMPUTED-TOMOGRAPHY; CARCINOMA; BRACHYTHERAPY; DELINEATION; GUIDELINES; STAGE; RECOMMENDATIONS; RADIOTHERAPY; MANAGEMENT; UPDATE;
D O I
10.1016/j.ejrad.2013.04.027
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: In patients with uterine cervical cancer, pretreatment recognition of uterine extension is crucial in treatment decision-making for fertility-sparing surgery and for target delineation in radiotherapy. Although MRI is generally considered the most reliable method, its value for detecting involvement of the uterine internal os is unclear. Methods: Medline, Embase and Cochrane databases were systematically searched (January 1997-December 2012) for MRI studies that measured the accuracy of involvement of the uterine internal os compared to histopathology as reference standard in patients with uterine cervical cancer. Data were assessed using the QUADAS tool. Accuracy concerned either involvement (yes/no) of the uterine internal os, or measuring invasion distance toward the uterine corpus. Results: Two retrospective and two prospective studies described 366 patients diagnosed with uterine cervical cancer FIGO stage IIB or below, in whom 64 (17%) had uterine internal os involvement. For three studies the summary estimates of specificity, sensitivity, negative predictive value (NPV), positive predictive value (PPV), and accuracy were 91%, 97%, 99%, 79% and 95%, respectively; one study had an area under the curve (AUC) of 0.8. Conclusion: MRI has a high level of accuracy; however, data are limited and for validation a large prospective study is needed that compares actual measurements on MRI with histopathological examination. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E422 / E428
页数:7
相关论文
共 27 条
[1]   Locally advanced cervical cancer: what is the standard of care? [J].
Al-Mansour, Zeina ;
Verschraegen, Claire .
CURRENT OPINION IN ONCOLOGY, 2010, 22 (05) :503-512
[2]   Can We Predict Vesicovaginal or Rectovaginal Fistula Formation in Patients With Stage IVA Cervical Cancer? [J].
Biewenga, Petra ;
Mutsaerts, Meike A. Q. ;
Stalpers, Lukas J. ;
Buist, Marrije R. ;
Schilthuis, Marten S. ;
van der Velden, Jacobus .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (03) :471-475
[3]   Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review [J].
Bipat, S ;
Glas, AS ;
van der Velden, J ;
Zwinderman, AH ;
Bossuyt, PMM ;
Stoker, J .
GYNECOLOGIC ONCOLOGY, 2003, 91 (01) :59-66
[4]   The role of magnetic resonance imaging in determining the proximal extension of early stage cervical cancer to the internal os [J].
Bipat, Shandra ;
van den Berg, Ryan A. ;
van der Velden, Jacobus ;
Stoker, Jaap ;
Spijkerboer, Anje M. .
EUROPEAN JOURNAL OF RADIOLOGY, 2011, 78 (01) :60-64
[5]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy [J].
Dimopoulos, Johannes C. A. ;
Petrow, Peter ;
Tanderup, Kari ;
Petric, Primoz ;
Berger, Daniel ;
Kirisits, Christian ;
Pedersen, Erik M. ;
van Limbergen, Erik ;
Haie-Meder, Christine ;
Poetter, Richard .
RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) :113-122
[6]   Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 [J].
Eifel, PJ ;
Winter, K ;
Morris, M ;
Levenback, C ;
Grigsby, PW ;
Cooper, J ;
Rotman, M ;
Gershenson, D ;
Mutch, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :872-880
[7]   Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer:: An update of the Dutch Deep Hyperthermia Trial [J].
Franckena, Martine ;
Stalpers, Lukas J. A. ;
Koper, Peter C. M. ;
Wiggenraad, Rudd G. J. ;
Hoogenraad, Wim J. ;
Duk, Jan D. P. van ;
Warlam-Rodenhuis, Carla C. ;
Jobsen, Jan J. ;
van Rhoon, Gerard C. ;
van der Zee, Jacoba .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :1176-1182
[8]   Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix - art. no. CD00225.pub2 [J].
Green, J ;
Kirwan, J ;
Tierney, J ;
Vale, C ;
Symonds, P ;
Fresco, L ;
Williams, C ;
Collingwood, M .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03)
[9]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV [J].
Haie-Meder, C ;
Pötter, R ;
Van Limbergen, E ;
Briot, E ;
De Brabandere, M ;
Dimopoulos, J ;
Dumas, I ;
Hellebust, TP ;
Kirisits, C ;
Lang, SF ;
Muschitz, S ;
Nevinson, J ;
Nulens, A ;
Petrow, P ;
Wachter-Gerstner, N .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :235-245
[10]   The role of imaging in the management of non-metastatic cervical cancer [J].
Kaidar-Person, Orit ;
Bortnyak-Abdah, Roxolyana ;
Amit, Amnon ;
Berniger, Alison ;
Ben-Yosef, Rahamim ;
Kuten, Abraham .
MEDICAL ONCOLOGY, 2012, 29 (05) :3389-3393